$7.54
6.91%
Nasdaq, Nov 22, 03:30 pm CET
ISIN
US89846A2078
Symbol
MEDS

Trxade Group Inc Stock price

$7.64
+0.24 3.24% 1M
+2.37 44.92% 6M
+4.40 136.01% YTD
+4.12 117.06% 1Y
-24.79 76.44% 3Y
-68.05 89.91% 5Y
-90.48 92.21% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.10 1.33%
ISIN
US89846A2078
Symbol
MEDS
Sector
Industry

Key metrics

Market capitalization $65.53m
Enterprise Value $58.00m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 13.09
P/S ratio (TTM) P/S ratio 14.79
P/B ratio (TTM) P/B ratio 0.91
Revenue growth (TTM) Revenue growth -53.02%
Revenue (TTM) Revenue $4.43m
EBIT (operating result TTM) EBIT $-14.03m
Free Cash Flow (TTM) Free Cash Flow $-7.44m
Cash position $7.72m
EPS (TTM) EPS $-26.96
Short interest 1.13%
Show more

Is Trxade Group Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Trxade Group Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Trxade Group Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Trxade Group Inc:

Buy
100%

Financial data from Trxade Group Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
4.43 4.43
53% 53%
100%
- Direct Costs 4.98 4.98
52% 52%
112%
-0.55 -0.55
109% 109%
-12%
- Selling and Administrative Expenses 12 12
70% 70%
280%
- Research and Development Expense - -
-
-
-13 -13
1,038% 1,038%
-293%
- Depreciation and Amortization 1.06 1.06
342% 342%
24%
EBIT (Operating Income) EBIT -14 -14
918% 918%
-317%
Net Profit -26 -26
525% 525%
-576%

In millions USD.

Don't miss a Thing! We will send you all news about Trxade Group Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Trxade Group Inc Stock News

Neutral
GlobeNewsWire
2 months ago
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced that it is changing its name to Scienture Holdings, Inc. (“Scienture Holdings”), effective Monday, September 23, 2024. Scienture Holdings stock will begin trading under the new ticker symbol NASDAQ:SCNX...
Neutral
GlobeNewsWire
4 months ago
TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced the appointment of Narasimhan Mani, Ph.D., MBA as Scienture's President. Shankar Hariharan, Ph.D., the current President and CEO, will be CEO of Scienture. Rahul Surana, Ph.D., MBA has been promoted to E...
Neutral
GlobeNewsWire
4 months ago
Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in an all-stock transaction valued at $103 million.
More Trxade Group Inc News

Company Profile

Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; and Other segments. The company operates a Web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a Web-based pharmaceutical marketplace; InventoryRx.com, a Web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, a desktop application, which provides product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; and Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics. Trxade Group, Inc. is based in Land O'Lakes, Florida.

Head office United States
CEO Surendra Ajjarapu
Employees 8
Founded 2005
Website www.scienture.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today